Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorbâ„¢-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose
Titel:
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorbâ„¢-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose
Auteur:
Gibson, C. Michael Mack, Michael J. Lee, Victoria T. Schneider, David J. Sellke, Frank W. Ohman, E. Magnus Thourani, Vinod H. Doros, Gheorghe Kroger, Hans Cutlip, Donald E. Deliargyris, Efthymios N.